Skip to main content
. 2019 Aug 30;11(9):1276. doi: 10.3390/cancers11091276
DCFH-DA 2’,7’-dichlorodihydrofluorescein diacetate
DiD′ 1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindodicarbocyanine, 4-Chlorobenzenesulfonate Salt
ERK1/2 extracellular signal–regulated kinase 1/2
EVs extracellular vesicles
IL interleukin
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-dephenyl tetrazolium bromide
NLRP3 nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain-containing 3
PC3-EVs PC3-derived extracellular vesicles
PCa prostate cancer
TAMs tumour associated macrophages
pCM conditioned medium of differentiated THP-1 cells, previously treated with PC3-Evs
PNT2-EVs PNT2-derived Evs
TPA 12-O-Tetradecanoilforbol-13-acetate